We are live on ! Find out more
IMPL

Impel Pharmaceuticals Inc. Common Stock

Delisted

IMPL was delisted on the 15th of December, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
VC
1
Vivo Capital
California
$43.3M
KKRC
2
Kohlberg Kravis Roberts & Co
New York
$15.5M
NA
3
NVP Associates
California
$11.5M +$11.2M +3,077,198 New
5VM
4
5AM Venture Management
California
$10.8M
VP
5
venBio Partners
California
$10.3M
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.93M +$736 +202 +0%
LM
7
Lasry Marc
$1.53M
DA
8
DCF Advisers
Connecticut
$1.22M -$522K -143,358 -31%
JGC
9
J. Goldman & Co
New York
$751K +$730K +200,219 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$578K +$20.4K +5,592 +4%
GGHC
11
Gilder Gagnon Howe & Co
New York
$535K -$237 -65 -0%
LCM
12
Laurion Capital Management
New York
$468K
Citadel Advisors
13
Citadel Advisors
Florida
$187K +$133K +36,542 +276%
State Street
14
State Street
Massachusetts
$141K -$15.3K -4,200 -10%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$132K
BCM
16
Bridgeway Capital Management
Texas
$125K -$128K -35,000 -51%
EP
17
EPIQ Partners
Minnesota
$69.9K
BlackRock
18
BlackRock
New York
$65.9K -$327K -89,684 -84%
Renaissance Technologies
19
Renaissance Technologies
New York
$58K -$7.29K -2,000 -11%
RJA
20
Raymond James & Associates
Florida
$54.4K +$52.8K +14,500 New
TFS
21
TrustCore Financial Services
Tennessee
$54K +$3.65K +1,000 +7%
BJL
22
Brighton Jones LLC
Washington
$53K
Northern Trust
23
Northern Trust
Illinois
$50.1K
Jane Street
24
Jane Street
New York
$49.3K +$47.9K +13,147 New
MP
25
McDonald Partners
Ohio
$43.9K +$42.6K +11,700 New